Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. Antengene Corporation Limited
  6. News
  7. Summary
    6996   KYG039571008

ANTENGENE CORPORATION LIMITED

(6996)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about ANTENGENE CORPORATION LIMITED
09/03ANTENGENE : Cancer Treatment Gets Approval for Phase 1 Clinical Trial in Australia; Shares..
MT
08/23ANTENGENE : Gets Chinese Regulator Nod for Phase 2 Trial of Potential Myelofibrosis Treatm..
MT
08/23ANTENGENE : Announces Approval of the Phase II Study of Selinexor for the Treatment of Mye..
PR
08/23Antengene Corporation Limited Announces Approval of the Phase II Study of Selinexor for..
CI
08/20Antengene Corporation Limited Announces Unaudited Consolidated Earnings Results for the..
CI
08/08Antengene Corporation Limited and MindRank AI Enter into Collaboration to Advance the D..
CI
07/30ANTENGENE : Voluntary announcement approval of nda by the mfds for atg-010 (selinexor) for..
PU
07/30Antengene Corporation Limited Announces the Approval of NDA by the MFDS for ATG-010 for..
CI
07/21Antengene Announces The Approval by Human Research Ethics Committeein Australia and to ..
CI
07/13ANTENGENE : Submits New Drug Application for Selinexor in Taiwan for the Treatment of Thre..
PR
07/06Antengene Announces Acceptance of IND Application in China for the Phase II Clinical Tr..
CI
07/05ANTENGENE : Announces Acceptance of IND Application in China for the Phase II Clinical Tri..
PR
06/21ANTENGENE CORPORATION LIMITED(SEHK : 6996) added to S&P Global BMI Index
CI
06/18Antengene Corporation Limited Announces Executive Changes
CI
06/11ANTENGENE : Founder And CEO Of Antengene, Dr. Jay Mei, Talks Innovation In Biotech, Passio..
AQ
More most relevant news
All news about ANTENGENE CORPORATION LIMITED
09/15Antengene Selected as a Constituent of the FTSE Global Equity Index Series
DJ
09/03ANTENGENE : Cancer Treatment Gets Approval for Phase 1 Clinical Trial in Australia; Shares..
MT
08/23ANTENGENE : Gets Chinese Regulator Nod for Phase 2 Trial of Potential Myelofibrosis Treatm..
MT
08/23ANTENGENE : Announces Approval of the Phase II Study of Selinexor for the Treatment of Mye..
PR
08/23Antengene Corporation Limited Announces Approval of the Phase II Study of Selinexor for..
CI
08/23Antengene Narrows H1 Loss on Lower Research and Development Costs
MT
08/20Antengene Corporation Limited Announces Unaudited Consolidated Earnings Results for the..
CI
08/08Antengene Corporation Limited and MindRank AI Enter into Collaboration to Advance the D..
CI
08/02KARYOPHARM THERAPEUTICS : Partner Antengene Says Cancer Drug Xpovio Gets Approval in South..
MT
07/30ANTENGENE : Voluntary announcement approval of nda by the mfds for atg-010 (selinexor) for..
PU
More news
News in other languages on ANTENGENE CORPORATION LIMITED

- No features available -

More news
Press releases
08/23ANTENGENE : Announces Approval of the Phase II Study of Selinexor for the Treatment of Mye..
PR
07/30ANTENGENE : Voluntary announcement approval of nda by the mfds for atg-010 (selinexor) for..
PU
07/13ANTENGENE : Submits New Drug Application for Selinexor in Taiwan for the Treatment of Thre..
PR
07/05ANTENGENE : Announces Acceptance of IND Application in China for the Phase II Clinical Tri..
PR
06/11ANTENGENE : Founder And CEO Of Antengene, Dr. Jay Mei, Talks Innovation In Biotech, Passio..
AQ
More press releases